Innovation
Entrepreneurship and innovation enable Weill Cornell Medicine to bring discoveries to patients faster.
Weill Cornell Medicine investigators enjoy robust programs dedicated to nurturing, protecting and commercializing their discoveries. By translating groundbreaking research into revolutionary care through commercial partnerships, lifechanging diagnostics, treatments and healthcare solutions can reach patients faster than ever before. Weill Cornell Medicine Enterprise Innovation fosters a culture of innovation and entrepreneurship to build the next generation of leaders in life sciences industries and new ventures.
News
Innovators Encourage Scientists and Physicians to Dive into Technology Commercialization
The Dean's Symposium celebrates innovation and Weill Cornell’s entrepreneurial spirit, while encouraging and motivating the next generation of innovators, inventors and entrepreneurs.
Multi-Disciplinary Program Hones Biomedical Commercialization Skills for Early-Career Scientists, Clinicians and Business Students
Anchor program developed by BioVenture eLab creates a culture and environment of entrepreneurial thinking as well as resources to spin out companies from Weill Cornell Medicine.
Licensing of PDX Model Repository Can Benefit Cancer Research Community
Champions Oncology signed a licensing agreement allowing it to distribute and commercialize PDX models generated at Weill Cornell Medicine.
Entrepreneurship Fuels Scientific Advancement for Early-Career Scientist
Dr. Cheuk Man Cherie Au, assistant professor of pharmacology research in medicine, shares her insights and experience navigating the realms of academia and entrepreneurship.
Views on Innovation
Dr. Barbara Hempstead, Dean, Weill Cornell Graduate School of Medical Sciences
Our accomplished physicians and scientists have a legacy of catalyzing research discoveries into new modalities and therapies that help transform human health.
Dr. John P. Leonard, Senior Associate Dean of Innovation and Initiatives
Getting new innovations across the finish line requires collaboration, often with industry partners, to scale up findings for application in healthcare.
Dr. William Polvino, CEO of Bridge Medicines
Tri-Institutional Therapeutics Discovery Institute and Bridge Medicines put the skill of a pharmaceutical company on the campuses of three great institutions.
Dr. Francis Barany, Professor of Microbiology and Immunology
The professionals at Enterprise Innovation possess strong first-hand knowledge of what it takes to start a company.
Become Engaged